Pharmacokinetics of levonorgestrel in the rat

Contraception (Impact Factor: 2.34). 08/1984; 30(1):81-8. DOI: 10.1016/0010-7824(84)90081-7
Source: PubMed


Levonorgestrel was administered intravenously as a bolus to adult female rats and blood samples were collected at various time intervals. Serum concentrations of levonorgestrel were measured by radioimmunoassay. Analysis of data for two- and three-compartment open models indicated that in the rat, as in the human and the rabbit, a tri-exponential equation provided a better fit of the data. The half-lives for the alpha, beta and gamma phases were 10.1 min, 42.7 min and 23.1 hours, respectively. These values were closer to those reported for women than were the half-lives reported for the rabbit. The alpha and the beta phases appeared to last for 51 min and 1.3 hours, respectively, and the gamma phase was longer than 45 hours.

2 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasma levels of levonorgestrel were determined by radioimmunoassay in eleven apparently healthy women belonging to the low socio-economic status, after the oral administration of two types of combination pills; one containing 500 μ dl-norgestrel and 30 μ ethynyl estradiol (Primovlar-30) and the other containing 150 μ d-norgestrel and 50 μ ethynyl estradiol (WHO-LNB pill). Analysis of the results revealed the following features: 1.1. With both preparations, plasma levels of levonorgestrel reached a peak between 1 and 2 hours after dosing and ranged from 4.6 to 16.2 ng/ml in the case of Primovlar-30 and 2.8 to 14.4 ng/ml with LNB. At 48 hours, the amount of levonorgestrel in circulation was found to be more than 0.5 ng/ml.2.2. The decline in plasma levels of the steroid was triphasic.3.3. Pharmacokinetic parameters calculated by graphical and regression analysis, showed that the elimination half-life ( β) of the drug showed a positive correlation and the peak plasma concentration a negative correlation with two anthropometric indices — weight/height2 × 100 and skin-fold at triceps.These data suggest that nutritional status as reflected by anthropometry can modify the disposition of levonorgestrel in women.
    Contraception 10/1979; 20(3):303-17. DOI:10.1016/0010-7824(79)90102-1 · 2.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A radioimmunoassay for levonorgestrel (Ng), which is applicable to plasma samples obtained from women who have taken a combination type oral contraceptive, has been developed and fully validated. Plasma concentrations of Ng rise to a peak of 3.6 ng/ml after an oral dose of 150 microgram and to 5.0 ng/ml after a 250 microgram dose. Following the intravenous administration of Ng, plasma concentrations of the steroid decline bi-exponentially with mean half-lives of 0.76 and 11.55 hours. Comparison of the results of the intravenous and oral administration of the steroid show a mean systemic bioavailability of 89% after the 150 microgram dose and 99% after a 250 microgram dose. This difference was not statistically significant. The values for volume of distribution were approximately half and the values for plasma clearance three times less than that previously reported for norethindrone. The plasma ethynylestradiol levels were also measured following administration of 30 microgram both intravenously and orally. The bioavailability and kinetics were similar to that previously reported for a 50 microgram dose. The peak values after oral dosing were 103 pg/ml and were reached by 1.0 hour in all subjects.
    Contraception 04/1981; 23(3):229-39. DOI:10.1016/0010-7824(81)90045-7 · 2.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Three women were each given 30 μg levonorgestrel in succession by the intravenous and oral routes. Another six women were given 150 μg levonorgestrel in the form of a MICROGYNON(R) coated tablet. Radiolabelled levonorgestrel was used for intravenous administration of 30 μg and oral administration of 150 μg. The plasma drug level was radioimmunoassayed after all treatments. In addition, after administration of levonorgestrel-3H the course of total plasma radioactivity and elimination with urine and faeces were measured. After intravenous and oral administration, drug concentration and total plasma radioactivity declined in two disposition phases whose half-lives were in the range of 1– and 1 day. In addition, after intravenous administration, an early phase with a half-life of about 10 min was observed. Absorption of levonorgestrel was rapid with a half-life of about 20 min. Orally administered doses were completely absorbed. It could be shown by means of an intra-individual comparison of the area under the drug level curve after intravenous and oral administration of the same dose that levonorgestrel is not subject to practically any first-pass effect.
    Contraception 04/1978; 17(3):207-20. DOI:10.1016/0010-7824(78)90012-4 · 2.34 Impact Factor